Portfolio of Biotech Stocks: First Portfolio

Here is a sample of 11 biotech stocks from the universe of biotechnology companies.


11 Biotech Stocks: First Portfolio

Stock Returns & Price Chart

Symbol

Recent Prices &
Annualized Return

Alexion PharmaceuticalsALXN
AllerganAGN
AmgenAMGN
Biogen IdecBIIB
Corcept TherapeuticsCORT
IncyteINCY
Sage TherapeuticsSAGE
Seattle GeneticsSGEN
Supernus PharmaceuticalsSUPN
The Medicines CompanyMDCO
Vertex PharmaceuticalsVRTX
Price data from Quandl as of most recent close.


11 Biotech Stocks: First Portfolio

Stock Returns & Price Chart

Symbol

Recent Dividends

Alexion PharmaceuticalsALXN
AllerganAGN
AmgenAMGN
Biogen IdecBIIB
Corcept TherapeuticsCORT
IncyteINCY
Sage TherapeuticsSAGE
Seattle GeneticsSGEN
Supernus PharmaceuticalsSUPN
The Medicines CompanyMDCO
Vertex PharmaceuticalsVRTX
Dividend chart data from Quandl as of today.


To inspect the performance of the Biotech Stocks: First Portfolio portfolio, see the chart below. Portfolio values are computed using monthly closes for stocks from Quandl.

The 9 stocks included in the portfolio computations are: ALXN, AGN, AMGN, BIIB, CORT, INCY, SGEN, MDCO and VRTX. The current value of the portfolio assumes that $1,111.11 was invested (total of $10,000) in each stock at its closing monthly price for the first date shown on the portfolio value chart below. All prices are adjusted for splits and dividends. SAGE and SUPN were excluded from the portfolio computations because of insufficient price data.

The current value of a $10,000 investment is $72,356. The percent return is 623.56%. The annualized return is 21.88%.




Return Summary for Biotech Stocks: First Portfolio
Start DateNov-30-2009
Start Investment$10,000.00
End DateNov-22-2019
Current Value of Investment$72,355.53
Total Return623.56%
Annualized Return21.88%
Min DateNov-30-2009
Min Price$10,000.00
Max DateNov-22-2019
Max Price$72,355.53
# Values121
Number Returns7,260
Number Profitable Returns6,393
Percent Profitable Returns88.06%
Number Unprofitable Returns867
Percent Unprofitable Returns11.94%
Profitable to Unprofitable Returns Ratio7.37



NOTE: The stocks included in the tables and chart are representative of the industry. They are not recommendations.


Related Portfolios

Portfolio of Biotech Stocks: Second Portfolio

Portfolio of Biotech Stocks: Diabetes

Portfolio of Dividend-Paying Pharmaceutical Stocks

Portfolio of Stem Cell Stocks